Metabolic Health
Beyond Blood Sugar: How GLP-1 Drugs Rewire the Cardiometabolic Network
A new gene-metabolite map suggests incretin-pathway drugs act on a web of cardiovascular and metabolic systems — not just glucose. Here's what that means for patients in 2026.